SIA
BMY icon

Stancorp Investment Advisers’s Bristol-Myers Squibb BMY Stock Holding History

Stancorp Investment Advisers’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		$1.15M Sell
17,767
-200
-1% -$12.5K 0.54% 54
2014
Q4 		$1.06M Buy
+17,967
New +$1.01M 0.49% 59

Other funds holding BMY

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Stancorp Investment Advisers's BMY Position: Q1 2015 in Review

Stancorp Investment Advisers reduced its Bristol-Myers Squibb (BMY) stake by 1.1% in Q1 2015, selling an estimated $12.5K and leaving 17,767 shares worth $1.15M. The position accounts for 0.54% of the portfolio, ranked #54.

Stancorp Investment Advisers first reported a position in BMY in Q4 2014 and has held it in 2 quarters since. 1,449 funds tracked by Wall St. Rank hold BMY as of Q1 2015.

  • Stancorp Investment Advisers held 17,767 shares of Bristol-Myers Squibb worth $1.15M as of Q1 2015.
  • Stancorp Investment Advisers sold 200 Bristol-Myers Squibb shares in Q1 2015, an estimated $12.5K.
  • Bristol-Myers Squibb made up 0.54% of Stancorp Investment Advisers's portfolio in Q1 2015, its #54 holding.
  • Stancorp Investment Advisers first reported a position in Bristol-Myers Squibb in Q4 2014 and has held it in 2 quarters since.
  • 1,449 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2015.

Based on Stancorp Investment Advisers's 13F filing for Q1 2015, filed 13 May 2015.